May 19 (Reuters) - CANTARGIA AB :CANTARGIA STRENGTHENS ORGANISATION WITH CFO.IS STRENGTHENING ITS ORGANISATION WITH A CHIEF FINANCIAL OFFICE, BENGT JÖNDELL..JÖNDELL HAS BEEN ACTING CFO AT ENZYMATICA AB..BENGT JÖNDELL WILL TAKE UP HIS POST AT CANTARGIA ON 22 MAY 2017..
May 18 (Reuters) - Sirtex Medical Ltd ::Kevin Richardson, CEO of Americas has ceased employment with company, effective immediately.
May 16 (Reuters) - Aveo Pharmaceuticals Inc -:Aveo announces appointment of Matthew Dallas as chief financial officer.Aveo Pharmaceuticals Inc - Dallas succeeds Keith Ehrlich, whose retirement from company was previously announced.Aveo Pharmaceuticals Inc - appointment of Matthew Dallas as chief financial officer, effective June 1, 2017.
May 16 (Reuters) - Insys Therapeutics Inc :Insys Therapeutics announces chief financial officer transition.Insys Therapeutics Inc - Darryl S. Baker, company's chief financial officer ("CFO"), will transition from role of CFO when a successor is hired.Insys Therapeutics Inc - Insys has engaged an executive search firm to support recruitment of a new CFO.
May 15 (Reuters) - Cytomx Therapeutics Inc :Cytomx announces management team changes.Bob Goeltz, chief financial officer, has decided to leave company to pursue new opportunities.Cytomx Therapeutics Inc - Cytomx is appointing Debanjan Ray as chief financial officer and head of corporate development, effective immediately.
May 15 (Reuters) - Actelion Ltd :Says Johnson & Johnson has appointed Jane Griffiths as global head of Actelion, to take effect upon closing of transaction.Says Otto Schwarz will retire from his position as chief operating officer upon close of transaction.
May 15 (Reuters) - Insmed Inc :Insmed announces key additions to its executive management team.Insmed inc says appointment of Paolo Tombesi as chief financial officer, effective June 1, 2017.Insmed inc says additionally, Eugene Sullivan has been appointed to newly created role of chief product strategy officer.
May 15 (Reuters) - Radius Health Inc :Radius Health appoints pharmaceutical executive Jose Carmona as Chief Financial Officer.Prior to joining Radius, Carmona was chief financial officer of Innocoll Holdings Plc.
May 12 (Reuters) - MOLECULAR PARTNERS AG ::PATRICK AMSTUTZ APPOINTED AS CHIEF EXECUTIVE OFFICER.
May 11 (Reuters) - Akari Therapeutics Plc :Akari Therapeutics says Gur Roshwalb, CEO, has been placed on administrative leave - sec filing.Akari Therapeutics says Ray Prudo in his role as executive chairman is temporarily assuming Roshwalb’S duties in his absence.Akari Therapeutics - board has established ad hoc special committee to review involvement, if any, of co personnel with Edison investment research report.